SUN PHARMACEUTICAL INDUSTRIES LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1137.1
- Today's High:
- ₹1154
- Open Price:
- ₹1144.95
- 52W Low:
- ₹781.2922
- 52W High:
- ₹1063.9059
- Prev. Close:
- ₹1137.1
- Volume:
- 207256
Company Statistics
- Market Cap.:
- ₹2,288.73 billion
- Book Value:
- 187.968
- Revenue TTM:
- ₹324.78 billion
- Operating Margin TTM:
- 16.16%
- Gross Profit TTM:
- ₹231.58 billion
- Profit Margin:
- 4.53%
- Return on Assets TTM:
- 4.94%
- Return on Equity TTM:
- 2.16%
Company Profile
SUN PHARMACEUTICAL INDUSTRIES LTD. had its IPO on under the ticker symbol SUNPHARMA.
The company operates in the Healthcare sector and Pharmaceuticals industry. SUN PHARMACEUTICAL INDUSTRIES LTD. has a staff strength of 36,000 employees.
Stock update
Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. opened at ₹1144.95 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1137.1 - ₹1154, and closed at ₹1145.15.
This is a +0.71% increase from the previous day's closing price.
A total volume of 207,256 shares were traded at the close of the day’s session.
In the last one week, shares of SUN PHARMACEUTICAL INDUSTRIES LTD. have increased by +3.29%.
SUN PHARMACEUTICAL INDUSTRIES LTD.'s Key Ratios
SUN PHARMACEUTICAL INDUSTRIES LTD. has a market cap of ₹2,288.73 billion, indicating a price to book ratio of 4.4842 and a price to sales ratio of 5.8518.
In the last 12-months SUN PHARMACEUTICAL INDUSTRIES LTD.’s revenue was ₹324.78 billion with a gross profit of ₹231.58 billion and an EBITDA of ₹72.21 billion. The EBITDA ratio measures SUN PHARMACEUTICAL INDUSTRIES LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, SUN PHARMACEUTICAL INDUSTRIES LTD.’s operating margin was 16.16% while its return on assets stood at 4.94% with a return of equity of 2.16%.
In Q4, SUN PHARMACEUTICAL INDUSTRIES LTD.’s quarterly earnings growth was a positive 70.7% while revenue growth was a positive 5.3%.
SUN PHARMACEUTICAL INDUSTRIES LTD.’s PE and PEG Ratio
- Forward PE
- 24.6305
- Trailing PE
- 317.0489
- PEG
Its diluted EPS in the last 12-months stands at ₹6.151 per share while it has a forward price to earnings multiple of 24.6305 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SUN PHARMACEUTICAL INDUSTRIES LTD.’s profitability.
SUN PHARMACEUTICAL INDUSTRIES LTD. stock is trading at a EV to sales ratio of 5.6084 and a EV to EBITDA ratio of 30.4597. Its price to sales ratio in the trailing 12-months stood at 5.8518.
SUN PHARMACEUTICAL INDUSTRIES LTD. stock pays annual dividends of ₹4 per share, indicating a yield of 0.42% and a payout ratio of 38.82%.
Balance sheet and cash flow metrics
- Total Assets
- ₹744.55 billion
- Total Liabilities
- ₹167.01 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 38.82%
SUN PHARMACEUTICAL INDUSTRIES LTD. ended 2024 with ₹744.55 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹744.55 billion while shareholder equity stood at ₹531.18 billion.
SUN PHARMACEUTICAL INDUSTRIES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹167.01 billion in other current liabilities, 2399300000.00 in common stock, ₹528.78 billion in retained earnings and ₹70.41 billion in goodwill. Its cash balance stood at ₹42.96 billion and cash and short-term investments were ₹145.89 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
SUN PHARMACEUTICAL INDUSTRIES LTD.’s total current assets stands at ₹390.03 billion while long-term investments were ₹0 and short-term investments were ₹92.28 billion. Its net receivables were ₹122.01 billion compared to accounts payable of ₹51.09 billion and inventory worth ₹98.75 billion.
In 2024, SUN PHARMACEUTICAL INDUSTRIES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, SUN PHARMACEUTICAL INDUSTRIES LTD. paid ₹0.39 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1145.15
- 52-Week High
- ₹1063.9059
- 52-Week Low
- ₹781.2922
- Analyst Target Price
- ₹
SUN PHARMACEUTICAL INDUSTRIES LTD. stock is currently trading at ₹1145.15 per share. It touched a 52-week high of ₹1063.9059 and a 52-week low of ₹1063.9059. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1111.42 and 200-day moving average was ₹1018.3 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5630.8% of the company’s stock are held by insiders while 2476.2% are held by institutions.
Frequently Asked Questions About SUN PHARMACEUTICAL INDUSTRIES LTD.
Similar Industry Stocks (Pharmaceuticals)
Most Active
Top Gainers
Top Losers
About
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, opthalomology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.